92 results
8-K
EX-99.1
BTAI
BioXcel Therapeutics Inc
22 Apr 24
Regulation FD Disclosure
7:10am
contracting J - Code granted by CMS effective Jan. 1, 2024 (streamlines and standardizes reimbursement) Over 250 hospital P&T approvals to date
8-K
EX-10.1
BTAI
BioXcel Therapeutics Inc
25 Mar 24
Entry into a Material Definitive Agreement
4:05pm
of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits
8-K
EX-99.1
im79oqcj6 g54d9et6
12 Mar 24
BioXcel Therapeutics Reports Financial Results for the Fourth Quarter and Full Year 2023
7:15am
8-K
EX-99.1
9r7y0c n2d
14 Feb 24
Regulation FD Disclosure
7:00am
8-K
EX-10.1
mw33o
8 Feb 24
Other Events
4:53pm
424B5
8d27kw6ndl5bdc7g18
14 Nov 23
Prospectus supplement for primary offering
8:57am
8-K
EX-99.1
xpc6bu k7
14 Nov 23
Results of Operations and Financial Condition
12:00am